Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Zaltrap
|
| gptkbp:appointed_by |
intravenous injection
|
| gptkbp:approves |
gptkb:2012
gptkb:FDA |
| gptkbp:class |
VEGF inhibitor
|
| gptkbp:developed_by |
gptkb:Zaltrap
|
| https://www.w3.org/2000/01/rdf-schema#label |
ziv-aflibercept
|
| gptkbp:is_used_for |
treatment of cancer
|
| gptkbp:marketed_as |
gptkb:Zaltrap
|
| gptkbp:social_structure |
recombinant fusion protein
|
| gptkbp:targets |
gptkb:vascular_endothelial_growth_factor_(VEGF)
|